Assessing the impact of an integrated health-system specialty pharmacy model on clinical disease activity index scores in patients with rheumatoid arthritis

This study showed that an HSSP model reduced the mean time to first fill of RA specialty medication and increased medication adherence but did not significantly change CDAI scores. Future studies with a larger patient population and more consistent CDAI documentation should be conducted to evaluate clinical outcomes based on pharmacy models.